Another depression trial goes bust, as Minerva drug fails PhII study
Depression trials tend to reap depressing results. Only weeks ago, Sage Therapeutics’ keenly anticipated pivotal trial in major depressive disorder (MDD)
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.